Global Animal-derived Immune Globulin Market Growth 2025-2031
The global Animal-derived Immune Globulin market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
LP Information, Inc. (LPI) ' newest research report, the “Animal-derived Immune Globulin Industry Forecast” looks at past sales and reviews total world Animal-derived Immune Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal-derived Immune Globulin sales for 2025 through 2031. With Animal-derived Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-derived Immune Globulin industry.
This Insight Report provides a comprehensive analysis of the global Animal-derived Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-derived Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal-derived Immune Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-derived Immune Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-derived Immune Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal-derived Immune Globulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Animal-derived Immune Globulin market?
What factors are driving Animal-derived Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal-derived Immune Globulin market opportunities vary by end market size?
How does Animal-derived Immune Globulin break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from ?2.6bn in 2015 to ?4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ?67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 228%.
LP Information, Inc. (LPI) ' newest research report, the “Animal-derived Immune Globulin Industry Forecast” looks at past sales and reviews total world Animal-derived Immune Globulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Animal-derived Immune Globulin sales for 2025 through 2031. With Animal-derived Immune Globulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Animal-derived Immune Globulin industry.
This Insight Report provides a comprehensive analysis of the global Animal-derived Immune Globulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Animal-derived Immune Globulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Animal-derived Immune Globulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Animal-derived Immune Globulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Animal-derived Immune Globulin.
This report presents a comprehensive overview, market shares, and growth opportunities of Animal-derived Immune Globulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Liquid
- Powder
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Rare Disease Therapeutics
- Merck
- Sanofi
- Wyeth Pharmaceuticals
- Protherics
- Genzyme
What is the 10-year outlook for the global Animal-derived Immune Globulin market?
What factors are driving Animal-derived Immune Globulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Animal-derived Immune Globulin market opportunities vary by end market size?
How does Animal-derived Immune Globulin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Animal-derived Immune Globulin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Animal-derived Immune Globulin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Animal-derived Immune Globulin by Country/Region, 2020, 2024 & 2031
2.2 Animal-derived Immune Globulin Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.3 Animal-derived Immune Globulin Sales by Type
2.3.1 Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
2.3.2 Global Animal-derived Immune Globulin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Animal-derived Immune Globulin Sale Price by Type (2020-2025)
2.4 Animal-derived Immune Globulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Animal-derived Immune Globulin Sales by Application
2.5.1 Global Animal-derived Immune Globulin Sale Market Share by Application (2020-2025)
2.5.2 Global Animal-derived Immune Globulin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Animal-derived Immune Globulin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Animal-derived Immune Globulin Breakdown Data by Company
3.1.1 Global Animal-derived Immune Globulin Annual Sales by Company (2020-2025)
3.1.2 Global Animal-derived Immune Globulin Sales Market Share by Company (2020-2025)
3.2 Global Animal-derived Immune Globulin Annual Revenue by Company (2020-2025)
3.2.1 Global Animal-derived Immune Globulin Revenue by Company (2020-2025)
3.2.2 Global Animal-derived Immune Globulin Revenue Market Share by Company (2020-2025)
3.3 Global Animal-derived Immune Globulin Sale Price by Company
3.4 Key Manufacturers Animal-derived Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal-derived Immune Globulin Product Location Distribution
3.4.2 Players Animal-derived Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANIMAL-DERIVED IMMUNE GLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Animal-derived Immune Globulin Market Size by Geographic Region (2020-2025)
4.1.1 Global Animal-derived Immune Globulin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Animal-derived Immune Globulin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Animal-derived Immune Globulin Market Size by Country/Region (2020-2025)
4.2.1 Global Animal-derived Immune Globulin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Animal-derived Immune Globulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal-derived Immune Globulin Sales Growth
4.4 APAC Animal-derived Immune Globulin Sales Growth
4.5 Europe Animal-derived Immune Globulin Sales Growth
4.6 Middle East & Africa Animal-derived Immune Globulin Sales Growth
5 AMERICAS
5.1 Americas Animal-derived Immune Globulin Sales by Country
5.1.1 Americas Animal-derived Immune Globulin Sales by Country (2020-2025)
5.1.2 Americas Animal-derived Immune Globulin Revenue by Country (2020-2025)
5.2 Americas Animal-derived Immune Globulin Sales by Type (2020-2025)
5.3 Americas Animal-derived Immune Globulin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal-derived Immune Globulin Sales by Region
6.1.1 APAC Animal-derived Immune Globulin Sales by Region (2020-2025)
6.1.2 APAC Animal-derived Immune Globulin Revenue by Region (2020-2025)
6.2 APAC Animal-derived Immune Globulin Sales by Type (2020-2025)
6.3 APAC Animal-derived Immune Globulin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Animal-derived Immune Globulin by Country
7.1.1 Europe Animal-derived Immune Globulin Sales by Country (2020-2025)
7.1.2 Europe Animal-derived Immune Globulin Revenue by Country (2020-2025)
7.2 Europe Animal-derived Immune Globulin Sales by Type (2020-2025)
7.3 Europe Animal-derived Immune Globulin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Animal-derived Immune Globulin by Country
8.1.1 Middle East & Africa Animal-derived Immune Globulin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Animal-derived Immune Globulin Revenue by Country (2020-2025)
8.2 Middle East & Africa Animal-derived Immune Globulin Sales by Type (2020-2025)
8.3 Middle East & Africa Animal-derived Immune Globulin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin
10.3 Manufacturing Process Analysis of Animal-derived Immune Globulin
10.4 Industry Chain Structure of Animal-derived Immune Globulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal-derived Immune Globulin Distributors
11.3 Animal-derived Immune Globulin Customer
12 WORLD FORECAST REVIEW FOR ANIMAL-DERIVED IMMUNE GLOBULIN BY GEOGRAPHIC REGION
12.1 Global Animal-derived Immune Globulin Market Size Forecast by Region
12.1.1 Global Animal-derived Immune Globulin Forecast by Region (2026-2031)
12.1.2 Global Animal-derived Immune Globulin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Animal-derived Immune Globulin Forecast by Type (2026-2031)
12.7 Global Animal-derived Immune Globulin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Animal-derived Immune Globulin Product Portfolios and Specifications
13.1.3 Pfizer Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Rare Disease Therapeutics
13.2.1 Rare Disease Therapeutics Company Information
13.2.2 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolios and Specifications
13.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rare Disease Therapeutics Main Business Overview
13.2.5 Rare Disease Therapeutics Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Animal-derived Immune Globulin Product Portfolios and Specifications
13.3.3 Merck Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Animal-derived Immune Globulin Product Portfolios and Specifications
13.4.3 Sanofi Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Wyeth Pharmaceuticals
13.5.1 Wyeth Pharmaceuticals Company Information
13.5.2 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolios and Specifications
13.5.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Wyeth Pharmaceuticals Main Business Overview
13.5.5 Wyeth Pharmaceuticals Latest Developments
13.6 Protherics
13.6.1 Protherics Company Information
13.6.2 Protherics Animal-derived Immune Globulin Product Portfolios and Specifications
13.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Protherics Main Business Overview
13.6.5 Protherics Latest Developments
13.7 Genzyme
13.7.1 Genzyme Company Information
13.7.2 Genzyme Animal-derived Immune Globulin Product Portfolios and Specifications
13.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Genzyme Main Business Overview
13.7.5 Genzyme Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Animal-derived Immune Globulin Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Animal-derived Immune Globulin by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Animal-derived Immune Globulin by Country/Region, 2020, 2024 & 2031
2.2 Animal-derived Immune Globulin Segment by Type
2.2.1 Liquid
2.2.2 Powder
2.3 Animal-derived Immune Globulin Sales by Type
2.3.1 Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
2.3.2 Global Animal-derived Immune Globulin Revenue and Market Share by Type (2020-2025)
2.3.3 Global Animal-derived Immune Globulin Sale Price by Type (2020-2025)
2.4 Animal-derived Immune Globulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Animal-derived Immune Globulin Sales by Application
2.5.1 Global Animal-derived Immune Globulin Sale Market Share by Application (2020-2025)
2.5.2 Global Animal-derived Immune Globulin Revenue and Market Share by Application (2020-2025)
2.5.3 Global Animal-derived Immune Globulin Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Animal-derived Immune Globulin Breakdown Data by Company
3.1.1 Global Animal-derived Immune Globulin Annual Sales by Company (2020-2025)
3.1.2 Global Animal-derived Immune Globulin Sales Market Share by Company (2020-2025)
3.2 Global Animal-derived Immune Globulin Annual Revenue by Company (2020-2025)
3.2.1 Global Animal-derived Immune Globulin Revenue by Company (2020-2025)
3.2.2 Global Animal-derived Immune Globulin Revenue Market Share by Company (2020-2025)
3.3 Global Animal-derived Immune Globulin Sale Price by Company
3.4 Key Manufacturers Animal-derived Immune Globulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Animal-derived Immune Globulin Product Location Distribution
3.4.2 Players Animal-derived Immune Globulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANIMAL-DERIVED IMMUNE GLOBULIN BY GEOGRAPHIC REGION
4.1 World Historic Animal-derived Immune Globulin Market Size by Geographic Region (2020-2025)
4.1.1 Global Animal-derived Immune Globulin Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Animal-derived Immune Globulin Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Animal-derived Immune Globulin Market Size by Country/Region (2020-2025)
4.2.1 Global Animal-derived Immune Globulin Annual Sales by Country/Region (2020-2025)
4.2.2 Global Animal-derived Immune Globulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Animal-derived Immune Globulin Sales Growth
4.4 APAC Animal-derived Immune Globulin Sales Growth
4.5 Europe Animal-derived Immune Globulin Sales Growth
4.6 Middle East & Africa Animal-derived Immune Globulin Sales Growth
5 AMERICAS
5.1 Americas Animal-derived Immune Globulin Sales by Country
5.1.1 Americas Animal-derived Immune Globulin Sales by Country (2020-2025)
5.1.2 Americas Animal-derived Immune Globulin Revenue by Country (2020-2025)
5.2 Americas Animal-derived Immune Globulin Sales by Type (2020-2025)
5.3 Americas Animal-derived Immune Globulin Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Animal-derived Immune Globulin Sales by Region
6.1.1 APAC Animal-derived Immune Globulin Sales by Region (2020-2025)
6.1.2 APAC Animal-derived Immune Globulin Revenue by Region (2020-2025)
6.2 APAC Animal-derived Immune Globulin Sales by Type (2020-2025)
6.3 APAC Animal-derived Immune Globulin Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Animal-derived Immune Globulin by Country
7.1.1 Europe Animal-derived Immune Globulin Sales by Country (2020-2025)
7.1.2 Europe Animal-derived Immune Globulin Revenue by Country (2020-2025)
7.2 Europe Animal-derived Immune Globulin Sales by Type (2020-2025)
7.3 Europe Animal-derived Immune Globulin Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Animal-derived Immune Globulin by Country
8.1.1 Middle East & Africa Animal-derived Immune Globulin Sales by Country (2020-2025)
8.1.2 Middle East & Africa Animal-derived Immune Globulin Revenue by Country (2020-2025)
8.2 Middle East & Africa Animal-derived Immune Globulin Sales by Type (2020-2025)
8.3 Middle East & Africa Animal-derived Immune Globulin Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin
10.3 Manufacturing Process Analysis of Animal-derived Immune Globulin
10.4 Industry Chain Structure of Animal-derived Immune Globulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Animal-derived Immune Globulin Distributors
11.3 Animal-derived Immune Globulin Customer
12 WORLD FORECAST REVIEW FOR ANIMAL-DERIVED IMMUNE GLOBULIN BY GEOGRAPHIC REGION
12.1 Global Animal-derived Immune Globulin Market Size Forecast by Region
12.1.1 Global Animal-derived Immune Globulin Forecast by Region (2026-2031)
12.1.2 Global Animal-derived Immune Globulin Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Animal-derived Immune Globulin Forecast by Type (2026-2031)
12.7 Global Animal-derived Immune Globulin Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Animal-derived Immune Globulin Product Portfolios and Specifications
13.1.3 Pfizer Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Rare Disease Therapeutics
13.2.1 Rare Disease Therapeutics Company Information
13.2.2 Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolios and Specifications
13.2.3 Rare Disease Therapeutics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Rare Disease Therapeutics Main Business Overview
13.2.5 Rare Disease Therapeutics Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Animal-derived Immune Globulin Product Portfolios and Specifications
13.3.3 Merck Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Animal-derived Immune Globulin Product Portfolios and Specifications
13.4.3 Sanofi Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Wyeth Pharmaceuticals
13.5.1 Wyeth Pharmaceuticals Company Information
13.5.2 Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolios and Specifications
13.5.3 Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Wyeth Pharmaceuticals Main Business Overview
13.5.5 Wyeth Pharmaceuticals Latest Developments
13.6 Protherics
13.6.1 Protherics Company Information
13.6.2 Protherics Animal-derived Immune Globulin Product Portfolios and Specifications
13.6.3 Protherics Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Protherics Main Business Overview
13.6.5 Protherics Latest Developments
13.7 Genzyme
13.7.1 Genzyme Company Information
13.7.2 Genzyme Animal-derived Immune Globulin Product Portfolios and Specifications
13.7.3 Genzyme Animal-derived Immune Globulin Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Genzyme Main Business Overview
13.7.5 Genzyme Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Animal-derived Immune Globulin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Animal-derived Immune Globulin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 6. Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Table 7. Global Animal-derived Immune Globulin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2025)
Table 9. Global Animal-derived Immune Globulin Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Animal-derived Immune Globulin Sale by Application (2020-2025) & (K MT)
Table 11. Global Animal-derived Immune Globulin Sale Market Share by Application (2020-2025)
Table 12. Global Animal-derived Immune Globulin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Animal-derived Immune Globulin Revenue Market Share by Application (2020-2025)
Table 14. Global Animal-derived Immune Globulin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Animal-derived Immune Globulin Sales by Company (2020-2025) & (K MT)
Table 16. Global Animal-derived Immune Globulin Sales Market Share by Company (2020-2025)
Table 17. Global Animal-derived Immune Globulin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Animal-derived Immune Globulin Revenue Market Share by Company (2020-2025)
Table 19. Global Animal-derived Immune Globulin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Animal-derived Immune Globulin Producing Area Distribution and Sales Area
Table 21. Players Animal-derived Immune Globulin Products Offered
Table 22. Animal-derived Immune Globulin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Animal-derived Immune Globulin Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Animal-derived Immune Globulin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Animal-derived Immune Globulin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Animal-derived Immune Globulin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Animal-derived Immune Globulin Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Animal-derived Immune Globulin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Animal-derived Immune Globulin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Animal-derived Immune Globulin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 34. Americas Animal-derived Immune Globulin Sales Market Share by Country (2020-2025)
Table 35. Americas Animal-derived Immune Globulin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 37. Americas Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 38. APAC Animal-derived Immune Globulin Sales by Region (2020-2025) & (K MT)
Table 39. APAC Animal-derived Immune Globulin Sales Market Share by Region (2020-2025)
Table 40. APAC Animal-derived Immune Globulin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 42. APAC Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 43. Europe Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 44. Europe Animal-derived Immune Globulin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 46. Europe Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Animal-derived Immune Globulin
Table 52. Key Market Challenges & Risks of Animal-derived Immune Globulin
Table 53. Key Industry Trends of Animal-derived Immune Globulin
Table 54. Animal-derived Immune Globulin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Animal-derived Immune Globulin Distributors List
Table 57. Animal-derived Immune Globulin Customer List
Table 58. Global Animal-derived Immune Globulin Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Animal-derived Immune Globulin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Animal-derived Immune Globulin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Animal-derived Immune Globulin Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Animal-derived Immune Globulin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Animal-derived Immune Globulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Animal-derived Immune Globulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Animal-derived Immune Globulin Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Animal-derived Immune Globulin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Animal-derived Immune Globulin Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Animal-derived Immune Globulin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Animal-derived Immune Globulin Product Portfolios and Specifications
Table 74. Pfizer Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Rare Disease Therapeutics Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 78. Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolios and Specifications
Table 79. Rare Disease Therapeutics Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Rare Disease Therapeutics Main Business
Table 81. Rare Disease Therapeutics Latest Developments
Table 82. Merck Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Animal-derived Immune Globulin Product Portfolios and Specifications
Table 84. Merck Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Sanofi Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Animal-derived Immune Globulin Product Portfolios and Specifications
Table 89. Sanofi Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. Wyeth Pharmaceuticals Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolios and Specifications
Table 94. Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Wyeth Pharmaceuticals Main Business
Table 96. Wyeth Pharmaceuticals Latest Developments
Table 97. Protherics Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 98. Protherics Animal-derived Immune Globulin Product Portfolios and Specifications
Table 99. Protherics Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Protherics Main Business
Table 101. Protherics Latest Developments
Table 102. Genzyme Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Genzyme Animal-derived Immune Globulin Product Portfolios and Specifications
Table 104. Genzyme Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Genzyme Main Business
Table 106. Genzyme Latest Developments
Table 1. Animal-derived Immune Globulin Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Animal-derived Immune Globulin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Liquid
Table 4. Major Players of Powder
Table 5. Global Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 6. Global Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Table 7. Global Animal-derived Immune Globulin Revenue by Type (2020-2025) & ($ million)
Table 8. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2025)
Table 9. Global Animal-derived Immune Globulin Sale Price by Type (2020-2025) & (USD/MT)
Table 10. Global Animal-derived Immune Globulin Sale by Application (2020-2025) & (K MT)
Table 11. Global Animal-derived Immune Globulin Sale Market Share by Application (2020-2025)
Table 12. Global Animal-derived Immune Globulin Revenue by Application (2020-2025) & ($ million)
Table 13. Global Animal-derived Immune Globulin Revenue Market Share by Application (2020-2025)
Table 14. Global Animal-derived Immune Globulin Sale Price by Application (2020-2025) & (USD/MT)
Table 15. Global Animal-derived Immune Globulin Sales by Company (2020-2025) & (K MT)
Table 16. Global Animal-derived Immune Globulin Sales Market Share by Company (2020-2025)
Table 17. Global Animal-derived Immune Globulin Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Animal-derived Immune Globulin Revenue Market Share by Company (2020-2025)
Table 19. Global Animal-derived Immune Globulin Sale Price by Company (2020-2025) & (USD/MT)
Table 20. Key Manufacturers Animal-derived Immune Globulin Producing Area Distribution and Sales Area
Table 21. Players Animal-derived Immune Globulin Products Offered
Table 22. Animal-derived Immune Globulin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Animal-derived Immune Globulin Sales by Geographic Region (2020-2025) & (K MT)
Table 26. Global Animal-derived Immune Globulin Sales Market Share Geographic Region (2020-2025)
Table 27. Global Animal-derived Immune Globulin Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Animal-derived Immune Globulin Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Animal-derived Immune Globulin Sales by Country/Region (2020-2025) & (K MT)
Table 30. Global Animal-derived Immune Globulin Sales Market Share by Country/Region (2020-2025)
Table 31. Global Animal-derived Immune Globulin Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Animal-derived Immune Globulin Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 34. Americas Animal-derived Immune Globulin Sales Market Share by Country (2020-2025)
Table 35. Americas Animal-derived Immune Globulin Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 37. Americas Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 38. APAC Animal-derived Immune Globulin Sales by Region (2020-2025) & (K MT)
Table 39. APAC Animal-derived Immune Globulin Sales Market Share by Region (2020-2025)
Table 40. APAC Animal-derived Immune Globulin Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 42. APAC Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 43. Europe Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 44. Europe Animal-derived Immune Globulin Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 46. Europe Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 47. Middle East & Africa Animal-derived Immune Globulin Sales by Country (2020-2025) & (K MT)
Table 48. Middle East & Africa Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Animal-derived Immune Globulin Sales by Type (2020-2025) & (K MT)
Table 50. Middle East & Africa Animal-derived Immune Globulin Sales by Application (2020-2025) & (K MT)
Table 51. Key Market Drivers & Growth Opportunities of Animal-derived Immune Globulin
Table 52. Key Market Challenges & Risks of Animal-derived Immune Globulin
Table 53. Key Industry Trends of Animal-derived Immune Globulin
Table 54. Animal-derived Immune Globulin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Animal-derived Immune Globulin Distributors List
Table 57. Animal-derived Immune Globulin Customer List
Table 58. Global Animal-derived Immune Globulin Sales Forecast by Region (2026-2031) & (K MT)
Table 59. Global Animal-derived Immune Globulin Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 61. Americas Animal-derived Immune Globulin Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Animal-derived Immune Globulin Sales Forecast by Region (2026-2031) & (K MT)
Table 63. APAC Animal-derived Immune Globulin Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 65. Europe Animal-derived Immune Globulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Animal-derived Immune Globulin Sales Forecast by Country (2026-2031) & (K MT)
Table 67. Middle East & Africa Animal-derived Immune Globulin Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Animal-derived Immune Globulin Sales Forecast by Type (2026-2031) & (K MT)
Table 69. Global Animal-derived Immune Globulin Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Animal-derived Immune Globulin Sales Forecast by Application (2026-2031) & (K MT)
Table 71. Global Animal-derived Immune Globulin Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Pfizer Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 73. Pfizer Animal-derived Immune Globulin Product Portfolios and Specifications
Table 74. Pfizer Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 75. Pfizer Main Business
Table 76. Pfizer Latest Developments
Table 77. Rare Disease Therapeutics Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 78. Rare Disease Therapeutics Animal-derived Immune Globulin Product Portfolios and Specifications
Table 79. Rare Disease Therapeutics Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 80. Rare Disease Therapeutics Main Business
Table 81. Rare Disease Therapeutics Latest Developments
Table 82. Merck Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 83. Merck Animal-derived Immune Globulin Product Portfolios and Specifications
Table 84. Merck Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 85. Merck Main Business
Table 86. Merck Latest Developments
Table 87. Sanofi Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 88. Sanofi Animal-derived Immune Globulin Product Portfolios and Specifications
Table 89. Sanofi Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 90. Sanofi Main Business
Table 91. Sanofi Latest Developments
Table 92. Wyeth Pharmaceuticals Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Wyeth Pharmaceuticals Animal-derived Immune Globulin Product Portfolios and Specifications
Table 94. Wyeth Pharmaceuticals Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 95. Wyeth Pharmaceuticals Main Business
Table 96. Wyeth Pharmaceuticals Latest Developments
Table 97. Protherics Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 98. Protherics Animal-derived Immune Globulin Product Portfolios and Specifications
Table 99. Protherics Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 100. Protherics Main Business
Table 101. Protherics Latest Developments
Table 102. Genzyme Basic Information, Animal-derived Immune Globulin Manufacturing Base, Sales Area and Its Competitors
Table 103. Genzyme Animal-derived Immune Globulin Product Portfolios and Specifications
Table 104. Genzyme Animal-derived Immune Globulin Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2025)
Table 105. Genzyme Main Business
Table 106. Genzyme Latest Developments
LIST OF FIGURES
Figure 1. Picture of Animal-derived Immune Globulin
Figure 2. Animal-derived Immune Globulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal-derived Immune Globulin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Animal-derived Immune Globulin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Animal-derived Immune Globulin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Animal-derived Immune Globulin Sales Market Share by Country/Region (2024)
Figure 10. Animal-derived Immune Globulin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Animal-derived Immune Globulin Sales Market Share by Type in 2025
Figure 14. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2025)
Figure 15. Animal-derived Immune Globulin Consumed in Hospital
Figure 16. Global Animal-derived Immune Globulin Market: Hospital (2020-2025) & (K MT)
Figure 17. Animal-derived Immune Globulin Consumed in Clinic
Figure 18. Global Animal-derived Immune Globulin Market: Clinic (2020-2025) & (K MT)
Figure 19. Global Animal-derived Immune Globulin Sale Market Share by Application (2024)
Figure 20. Global Animal-derived Immune Globulin Revenue Market Share by Application in 2025
Figure 21. Animal-derived Immune Globulin Sales by Company in 2025 (K MT)
Figure 22. Global Animal-derived Immune Globulin Sales Market Share by Company in 2025
Figure 23. Animal-derived Immune Globulin Revenue by Company in 2025 ($ millions)
Figure 24. Global Animal-derived Immune Globulin Revenue Market Share by Company in 2025
Figure 25. Global Animal-derived Immune Globulin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Animal-derived Immune Globulin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 28. Americas Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 29. APAC Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 30. APAC Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 31. Europe Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 32. Europe Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 35. Americas Animal-derived Immune Globulin Sales Market Share by Country in 2025
Figure 36. Americas Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 38. Americas Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 39. United States Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Animal-derived Immune Globulin Sales Market Share by Region in 2025
Figure 44. APAC Animal-derived Immune Globulin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 46. APAC Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 47. China Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Animal-derived Immune Globulin Sales Market Share by Country in 2025
Figure 55. Europe Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 57. Europe Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 58. Germany Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 59. France Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin in 2025
Figure 72. Manufacturing Process Analysis of Animal-derived Immune Globulin
Figure 73. Industry Chain Structure of Animal-derived Immune Globulin
Figure 74. Channels of Distribution
Figure 75. Global Animal-derived Immune Globulin Sales Market Forecast by Region (2026-2031)
Figure 76. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Animal-derived Immune Globulin Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Animal-derived Immune Globulin Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Animal-derived Immune Globulin
Figure 2. Animal-derived Immune Globulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Animal-derived Immune Globulin Sales Growth Rate 2020-2031 (K MT)
Figure 7. Global Animal-derived Immune Globulin Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Animal-derived Immune Globulin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Animal-derived Immune Globulin Sales Market Share by Country/Region (2024)
Figure 10. Animal-derived Immune Globulin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Global Animal-derived Immune Globulin Sales Market Share by Type in 2025
Figure 14. Global Animal-derived Immune Globulin Revenue Market Share by Type (2020-2025)
Figure 15. Animal-derived Immune Globulin Consumed in Hospital
Figure 16. Global Animal-derived Immune Globulin Market: Hospital (2020-2025) & (K MT)
Figure 17. Animal-derived Immune Globulin Consumed in Clinic
Figure 18. Global Animal-derived Immune Globulin Market: Clinic (2020-2025) & (K MT)
Figure 19. Global Animal-derived Immune Globulin Sale Market Share by Application (2024)
Figure 20. Global Animal-derived Immune Globulin Revenue Market Share by Application in 2025
Figure 21. Animal-derived Immune Globulin Sales by Company in 2025 (K MT)
Figure 22. Global Animal-derived Immune Globulin Sales Market Share by Company in 2025
Figure 23. Animal-derived Immune Globulin Revenue by Company in 2025 ($ millions)
Figure 24. Global Animal-derived Immune Globulin Revenue Market Share by Company in 2025
Figure 25. Global Animal-derived Immune Globulin Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Animal-derived Immune Globulin Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 28. Americas Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 29. APAC Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 30. APAC Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 31. Europe Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 32. Europe Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Animal-derived Immune Globulin Sales 2020-2025 (K MT)
Figure 34. Middle East & Africa Animal-derived Immune Globulin Revenue 2020-2025 ($ millions)
Figure 35. Americas Animal-derived Immune Globulin Sales Market Share by Country in 2025
Figure 36. Americas Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Figure 37. Americas Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 38. Americas Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 39. United States Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Animal-derived Immune Globulin Sales Market Share by Region in 2025
Figure 44. APAC Animal-derived Immune Globulin Revenue Market Share by Region (2020-2025)
Figure 45. APAC Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 46. APAC Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 47. China Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 51. India Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Animal-derived Immune Globulin Sales Market Share by Country in 2025
Figure 55. Europe Animal-derived Immune Globulin Revenue Market Share by Country (2020-2025)
Figure 56. Europe Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 57. Europe Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 58. Germany Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 59. France Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Animal-derived Immune Globulin Sales Market Share by Application (2020-2025)
Figure 66. Egypt Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Animal-derived Immune Globulin Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Animal-derived Immune Globulin in 2025
Figure 72. Manufacturing Process Analysis of Animal-derived Immune Globulin
Figure 73. Industry Chain Structure of Animal-derived Immune Globulin
Figure 74. Channels of Distribution
Figure 75. Global Animal-derived Immune Globulin Sales Market Forecast by Region (2026-2031)
Figure 76. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Animal-derived Immune Globulin Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Animal-derived Immune Globulin Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Animal-derived Immune Globulin Revenue Market Share Forecast by Application (2026-2031)
